Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02347969
Other study ID # DE-87
Secondary ID
Status Completed
Phase N/A
First received January 16, 2015
Last updated September 20, 2016
Start date October 2014
Est. completion date March 2016

Study information

Verified date March 2016
Source Nutratech Conseils
Contact n/a
Is FDA regulated No
Health authority France: Agence Nationale de Sécurité du Médicament et des produits de santé
Study type Interventional

Clinical Trial Summary

The main objective of this trial is to evaluate the effect of the daily dose of X34 dietary supplement on skin radiance (clinical assessment) for 8 weeks.


Other known NCT identifiers
  • NCT02352415

Recruitment information / eligibility

Status Completed
Enrollment 35
Est. completion date March 2016
Est. primary completion date March 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 40 Years to 70 Years
Eligibility Inclusion Criteria:

- Female volunteers:

- Age: 40-70 years

- Who have a dull complexion evaluated by clinical scoring

- Phototype II to IV (annex 5)

- Non-smoking or smoking less than 5 cigarettes per day

- Did not change her eating habits, within one month before the start of the study and agreeing not change during the study

- With no history of facial skin care (peeling, mask…) 15 days before the beginning of the study and agreeing not to perform during the study

- Volunteers accepting not changing their local treatment on face

- Who agree to avoid UV exposure (sun or tanning booth) during the study

- Who have a fixed address and are entitled to Social Security or a similar National Insurance scheme

- Who sign a written informed consent

Exclusion Criteria:

- Pregnant, nursing, or intending to become pregnant in the course of the study

- With a history of allergy or hypersensitivity to the products or one of their components

- Having use oral nutritional supplements and/or vitamin supplementation less than one month before and/or refusing not consuming nutritional supplement during the study

- Having used cosmetics and/or topical preparations containing ingredients claiming efficacy on skin radiance less than 15 days before and/or during the study

- With a dermatosis, systemic disease or treatment susceptible to interfere with the evolution of the parameters of the study or with taking the nutritional supplement

- Participation in another clinical trial evaluating skin radiance during the last month before the study

- Participation in another clinical trial or volunteers being in the exclusion phase of such a trial, thus being unable to participate in any other one

- Who have forfeited their freedom by judiciary decision or are deemed legally incompetent

- Having perceived more than 4500 € as indemnification fees for participation in clinical trials during the preceding 12 months (including participation in this clinical trial)

- Unable to comply with the protocol constraints

- Who cannot be contacted by phone rapidly

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
X34
Dietary supplement named X34

Locations

Country Name City State
n/a

Sponsors (6)

Lead Sponsor Collaborator
Nutratech Conseils Centre Hospitalier Universitaire de Besancon, Clinical Investigation Center (CIC) INSERM 1431, INSERM UMR1098, Research and Studies Center on the Integument (CERT), University of Franche-Comté

Outcome

Type Measure Description Time frame Safety issue
Primary Skin radiance: clinical scoring At 0 week and 8 weeks No
Secondary Subject self-assessments Subjects will evaluate the radiance of their complexion by self-assessment. At 0 week and 8 weeks No
See also
  Status Clinical Trial Phase
Completed NCT05029518 - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability Phase 1
Completed NCT05001152 - Taste Assessment of Ozanimod Phase 1
Completed NCT04493255 - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants Phase 1
Completed NCT03457649 - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers Phase 1
Completed NCT00995891 - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Completed NCT05050318 - Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Phase 4
Completed NCT05043766 - Evaluation of Oral PF614 Relative to OxyContin Phase 1
Completed NCT04466748 - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects Phase 1
Completed NCT00746733 - Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC Phase 1
Recruiting NCT05929651 - Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy Phase 4
Completed NCT05954039 - Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect N/A
Completed NCT05045716 - A Study of Subcutaneous Lecanemab in Healthy Participants Phase 1
Active, not recruiting NCT02747927 - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Phase 3
Completed NCT05533801 - A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Phase 1
Not yet recruiting NCT03931369 - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) Phase 2
Completed NCT03279146 - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects Phase 1
Completed NCT06027437 - A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants Phase 1
Recruiting NCT05619874 - Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity N/A
Completed NCT05553418 - Investigational On-body Injector Clinical Study N/A
Completed NCT04092712 - Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers Phase 1